SECsense Logo

Bionano Genomics 8-K Report: Key Updates & Corporate Changes (Jan 2025)

$BNGO
Form 8-K
Filed on: 2025-01-06
Source
Bionano Genomics 8-K Report: Key Updates & Corporate Changes (Jan 2025)

Based on the provided XML section of the financial report, here are the key insights extracted:

  1. Company Information:
  • Name: Bionano Genomics, Inc.
  • CIK Number: 0001411690
  • LEI: 26-1756290
  • Address: 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121
  • Contact Number: 858-888-7600
  • State of Incorporation: Delaware (DE)
  1. Filing Information:
  • Document Type: Form 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: January 3, 2025
  1. Security Information:
  • Type of Security: Common Stock
  • Par Value: $0.0001 per share
  • Ticker Symbol: BNGO
  • Exchange: NASDAQ
  1. Reporting Period:
  • Reporting Date: January 3, 2025

Insights:

  • The filing is a Form 8-K, which typically indicates important events that shareholders should be aware of, such as acquisitions, changes in management, or other significant developments.
  • The company's common stock is publicly traded on NASDAQ, which suggests it has a level of regulatory scrutiny and transparency due to its reporting obligations.
  • The par value of the common stock is relatively low, which may imply a focus on growth and investment rather than immediate returns to shareholders.

Overall, this report section indicates that Bionano Genomics is actively updating stakeholders about significant corporate events and is maintaining compliance with SEC regulations.